Huahai Pharmaceutical (600521.SH) issued an announcement. The company recently received the “Drug Registration Certificate” for torasemide tablets approved and issued by the State Drug Administration. Torasemide tablets are used to treat oedema associated with heart failure, kidney disease, or liver disease; for treating high blood pressure, this product can be used alone or in combination with other antihypertensive drugs.
华海药业(600521.SH)获得托拉塞米片药品注册证书
Huahai Pharmaceutical (600521.SH) obtained torasemide tablet drug registration certificate
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.